Cargando…

New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options

Heart transplantation (HT) is the established treatment for end-stage heart failure, significantly enhancing patients’ survival and quality of life. To ensure optimal outcomes, the routine monitoring of HT recipients is paramount. While existing guidelines offer guidance on a blend of invasive and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Pergola, Valeria, Mattesi, Giulia, Cozza, Elena, Pradegan, Nicola, Tessari, Chiara, Dellino, Carlo Maria, Savo, Maria Teresa, Amato, Filippo, Cecere, Annagrazia, Perazzolo Marra, Martina, Tona, Francesco, Guaricci, Andrea Igoren, De Conti, Giorgio, Gerosa, Gino, Iliceto, Sabino, Motta, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487200/
https://www.ncbi.nlm.nih.gov/pubmed/37685356
http://dx.doi.org/10.3390/diagnostics13172818
_version_ 1785103183216902144
author Pergola, Valeria
Mattesi, Giulia
Cozza, Elena
Pradegan, Nicola
Tessari, Chiara
Dellino, Carlo Maria
Savo, Maria Teresa
Amato, Filippo
Cecere, Annagrazia
Perazzolo Marra, Martina
Tona, Francesco
Guaricci, Andrea Igoren
De Conti, Giorgio
Gerosa, Gino
Iliceto, Sabino
Motta, Raffaella
author_facet Pergola, Valeria
Mattesi, Giulia
Cozza, Elena
Pradegan, Nicola
Tessari, Chiara
Dellino, Carlo Maria
Savo, Maria Teresa
Amato, Filippo
Cecere, Annagrazia
Perazzolo Marra, Martina
Tona, Francesco
Guaricci, Andrea Igoren
De Conti, Giorgio
Gerosa, Gino
Iliceto, Sabino
Motta, Raffaella
author_sort Pergola, Valeria
collection PubMed
description Heart transplantation (HT) is the established treatment for end-stage heart failure, significantly enhancing patients’ survival and quality of life. To ensure optimal outcomes, the routine monitoring of HT recipients is paramount. While existing guidelines offer guidance on a blend of invasive and non-invasive imaging techniques, certain aspects such as the timing of echocardiographic assessments and the role of echocardiography or cardiac magnetic resonance (CMR) as alternatives to serial endomyocardial biopsies (EMBs) for rejection monitoring are not specifically outlined in the guidelines. Furthermore, invasive coronary angiography (ICA) is still recommended as the gold-standard procedure, usually performed one year after surgery and every two years thereafter. This review focuses on recent advancements in non-invasive and contrast-saving imaging techniques that have been investigated for HT patients. The aim of the manuscript is to identify imaging modalities that may potentially replace or reduce the need for invasive procedures such as ICA and EMB, considering their respective advantages and disadvantages. We emphasize the transformative potential of non-invasive techniques in elevating patient care. Advanced echocardiography techniques, including strain imaging and tissue Doppler imaging, offer enhanced insights into cardiac function, while CMR, through its multi-parametric mapping techniques, such as T1 and T2 mapping, allows for the non-invasive assessment of inflammation and tissue characterization. Cardiac computed tomography (CCT), particularly with its ability to evaluate coronary artery disease and assess graft vasculopathy, emerges as an integral tool in the follow-up of HT patients. Recent studies have highlighted the potential of nuclear myocardial perfusion imaging, including myocardial blood flow quantification, as a non-invasive method for diagnosing and prognosticating CAV. These advanced imaging approaches hold promise in mitigating the need for invasive procedures like ICA and EMB when evaluating the benefits and limitations of each modality.
format Online
Article
Text
id pubmed-10487200
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104872002023-09-09 New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options Pergola, Valeria Mattesi, Giulia Cozza, Elena Pradegan, Nicola Tessari, Chiara Dellino, Carlo Maria Savo, Maria Teresa Amato, Filippo Cecere, Annagrazia Perazzolo Marra, Martina Tona, Francesco Guaricci, Andrea Igoren De Conti, Giorgio Gerosa, Gino Iliceto, Sabino Motta, Raffaella Diagnostics (Basel) Review Heart transplantation (HT) is the established treatment for end-stage heart failure, significantly enhancing patients’ survival and quality of life. To ensure optimal outcomes, the routine monitoring of HT recipients is paramount. While existing guidelines offer guidance on a blend of invasive and non-invasive imaging techniques, certain aspects such as the timing of echocardiographic assessments and the role of echocardiography or cardiac magnetic resonance (CMR) as alternatives to serial endomyocardial biopsies (EMBs) for rejection monitoring are not specifically outlined in the guidelines. Furthermore, invasive coronary angiography (ICA) is still recommended as the gold-standard procedure, usually performed one year after surgery and every two years thereafter. This review focuses on recent advancements in non-invasive and contrast-saving imaging techniques that have been investigated for HT patients. The aim of the manuscript is to identify imaging modalities that may potentially replace or reduce the need for invasive procedures such as ICA and EMB, considering their respective advantages and disadvantages. We emphasize the transformative potential of non-invasive techniques in elevating patient care. Advanced echocardiography techniques, including strain imaging and tissue Doppler imaging, offer enhanced insights into cardiac function, while CMR, through its multi-parametric mapping techniques, such as T1 and T2 mapping, allows for the non-invasive assessment of inflammation and tissue characterization. Cardiac computed tomography (CCT), particularly with its ability to evaluate coronary artery disease and assess graft vasculopathy, emerges as an integral tool in the follow-up of HT patients. Recent studies have highlighted the potential of nuclear myocardial perfusion imaging, including myocardial blood flow quantification, as a non-invasive method for diagnosing and prognosticating CAV. These advanced imaging approaches hold promise in mitigating the need for invasive procedures like ICA and EMB when evaluating the benefits and limitations of each modality. MDPI 2023-08-31 /pmc/articles/PMC10487200/ /pubmed/37685356 http://dx.doi.org/10.3390/diagnostics13172818 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Pergola, Valeria
Mattesi, Giulia
Cozza, Elena
Pradegan, Nicola
Tessari, Chiara
Dellino, Carlo Maria
Savo, Maria Teresa
Amato, Filippo
Cecere, Annagrazia
Perazzolo Marra, Martina
Tona, Francesco
Guaricci, Andrea Igoren
De Conti, Giorgio
Gerosa, Gino
Iliceto, Sabino
Motta, Raffaella
New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options
title New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options
title_full New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options
title_fullStr New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options
title_full_unstemmed New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options
title_short New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options
title_sort new non-invasive imaging technologies in cardiac transplant follow-up: acquired evidence and future options
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487200/
https://www.ncbi.nlm.nih.gov/pubmed/37685356
http://dx.doi.org/10.3390/diagnostics13172818
work_keys_str_mv AT pergolavaleria newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT mattesigiulia newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT cozzaelena newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT pradegannicola newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT tessarichiara newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT dellinocarlomaria newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT savomariateresa newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT amatofilippo newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT cecereannagrazia newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT perazzolomarramartina newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT tonafrancesco newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT guaricciandreaigoren newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT decontigiorgio newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT gerosagino newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT ilicetosabino newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions
AT mottaraffaella newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions